{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:21:58Z","timestamp":1772781718608,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-025-01725-7","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T21:16:38Z","timestamp":1745356598000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["RETRACTED ARTICLE: Efficacy of lactoferrin in preventing recurrent urinary tract infections in pregnant Egyptian women: a randomized controlled trial"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3422-3822","authenticated-orcid":false,"given":"Ahmed","family":"Shoukry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasser","family":"ElKassar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaella K.","family":"Hezagirwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rehab","family":"El-Said","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"1725_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.puhe.2023.08.016","volume":"224","author":"N Salari","year":"2023","unstructured":"Salari N, Khoshbakht Y, Hemmati M, Khodayari Y, Khaleghi AA, Jafari F, Shohaimi S, Mohammadi M. Global prevalence of urinary tract infection in pregnant mothers: a systematic review and meta-analysis. Public Health. 2023;224:58\u201365.","journal-title":"Public Health"},{"key":"1725_CR2","doi-asserted-by":"publisher","first-page":"965053","DOI":"10.3389\/fmicb.2022.965053","volume":"13","author":"K Bhargava","year":"2022","unstructured":"Bhargava K, Nath G, Bhargava A, Kumari R, Aseri GK, Jain N. Bacterial profile and antibiotic susceptibility pattern of uropathogens causing urinary tract infection in the eastern part of Northern India. Front Microbiol. 2022;13: 965053.","journal-title":"Front Microbiol"},{"issue":"3","key":"1725_CR3","doi-asserted-by":"publisher","first-page":"e013198","DOI":"10.1136\/bmjopen-2016-013198","volume":"7","author":"M Abdel-Aziz Elzayat","year":"2017","unstructured":"Abdel-Aziz Elzayat M, Barnett-Vanes A, Dabour MF, Cheng F. Prevalence of undiagnosed asymptomatic bacteriuria and associated risk factors during pregnancy: a cross-sectional study at two tertiary centres in Cairo\u00a0Egypt. BMJ Open. 2017;7(3):e013198.","journal-title":"BMJ Open"},{"issue":"3","key":"1725_CR4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.9790\/1959-0603076272","volume":"6","author":"NR Mohamed","year":"2017","unstructured":"Mohamed NR, Omar HH, Abd-Allah IM. Prevalence and risk factors of urinary tract infection among pregnant women in Ismailia City. Egypt IOSR J Nurs Health Sci. 2017;6(3):62\u201372.","journal-title":"Egypt IOSR J Nurs Health Sci"},{"issue":"1","key":"1725_CR5","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/s41598-022-05452-z","volume":"12","author":"AH Ali","year":"2022","unstructured":"Ali AH, Reda DY, Ormago MD. Prevalence and antimicrobial susceptibility pattern of urinary tract infection among pregnant women attending Hargeisa Group Hospital, Hargeisa, Somaliland. Sci Rep. 2022;12(1):1419.","journal-title":"Sci Rep"},{"issue":"6","key":"1725_CR6","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00192-014-2569-5","volume":"26","author":"A Aydin","year":"2015","unstructured":"Aydin A, Ahmed K, Zaman I, Khan MS, Dasgupta P. Recurrent urinary tract infections in women. Int Urogynecol J. 2015;26(6):795\u2013804.","journal-title":"Int Urogynecol J"},{"issue":"4","key":"1725_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0924-8579(00)00350-2","volume":"17","author":"TM Hooton","year":"2001","unstructured":"Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents. 2001;17(4):259\u201368.","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"1725_CR8","first-page":"CD009279","volume":"2015","author":"C Schneeberger","year":"2015","unstructured":"Schneeberger C, Geerlings SE, Middleton P, Crowther CA. Interventions for preventing recurrent urinary tract infection during pregnancy. Cochrane Database Syst Rev. 2015;2015(7):CD009279.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1725_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4314\/ejhs.v25i1.2","volume":"25","author":"BH Oladeinde","year":"2015","unstructured":"Oladeinde BH, Omoregie R, Oladeinde OB. Asymptomatic urinary tract infection among pregnant women receiving ante-natal care in a traditional birth home in Benin City\u00a0Nigeria. Ethiop J Health Sci. 2015;25(1):3\u20138.","journal-title":"Ethiop J Health Sci"},{"issue":"17","key":"1725_CR10","doi-asserted-by":"publisher","first-page":"E625","DOI":"10.1503\/cmaj.161020","volume":"189","author":"FT Muanda","year":"2017","unstructured":"Muanda FT, Sheehy O, Berard A. Use of antibiotics during pregnancy and risk of spontaneous abortion. CMAJ. 2017;189(17):E625\u201333.","journal-title":"CMAJ"},{"issue":"11","key":"1725_CR11","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/bdra.23570","volume":"106","author":"EC Ailes","year":"2016","unstructured":"Ailes EC, Gilboa SM, Gill SK, Broussard CS, Crider KS, Berry RJ, Carter TC, Hobbs CA, Interrante JD, Reefhuis J, et al. Association between antibiotic use among pregnant women with urinary tract infections in the first trimester and birth defects, National Birth Defects Prevention Study 1997 to 2011. Birth Defects Res A Clin Mol Teratol. 2016;106(11):940\u20139.","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"9646","key":"1725_CR12","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S0140-6736(08)61203-9","volume":"372","author":"S Kenyon","year":"2008","unstructured":"Kenyon S, Pike K, Jones DR, Brocklehurst P, Marlow N, Salt A, Taylor DJ. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet. 2008;372(9646):1319\u201327.","journal-title":"Lancet"},{"issue":"11","key":"1725_CR13","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/S1701-2163(16)34717-X","volume":"32","author":"A Epp","year":"2010","unstructured":"Epp A, Larochelle A, Urogynaecology C. Family physicians advisory C: Recurrent urinary tract infection. J Obstet Gynaecol Can. 2010;32(11):1082\u201390.","journal-title":"J Obstet Gynaecol Can"},{"key":"1725_CR14","first-page":"233","volume":"10","author":"S Moradpour","year":"2021","unstructured":"Moradpour S, Shahnazi H, Hassanzadeh A. Predictability of constructs of theory of planned behavior in adopting urinary tract infection prevention behaviors among pregnant women. J Educ Health Promot. 2021;10:233.","journal-title":"J Educ Health Promot"},{"issue":"10","key":"1725_CR15","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.2105\/AJPH.92.10.1609","volume":"92","author":"T Alraek","year":"2002","unstructured":"Alraek T, Soedal LI, Fagerheim SU, Digranes A, Baerheim A. Acupuncture treatment in the prevention of uncomplicated recurrent lower urinary tract infections in adult women. Am J Public Health. 2002;92(10):1609\u201311.","journal-title":"Am J Public Health"},{"issue":"10","key":"1725_CR16","first-page":"CD001321","volume":"10","author":"RG Jepson","year":"2012","unstructured":"Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2012;10(10):CD001321.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"1725_CR17","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.juro.2008.06.016","volume":"180","author":"DA Wing","year":"2008","unstructured":"Wing DA, Rumney PJ, Preslicka CW, Chung JH. Daily cranberry juice for the prevention of asymptomatic bacteriuria in pregnancy: a randomized, controlled pilot study. J Urol. 2008;180(4):1367\u201372.","journal-title":"J Urol"},{"issue":"7","key":"1725_CR18","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1080\/00016340701273189","volume":"86","author":"GJ Ochoa-Brust","year":"2007","unstructured":"Ochoa-Brust GJ, Fernandez AR, Villanueva-Ruiz GJ, Velasco R, Trujillo-Hernandez B, Vasquez C. Daily intake of 100 mg ascorbic acid as urinary tract infection prophylactic agent during pregnancy. Acta Obstet Gynecol Scand. 2007;86(7):783\u20137.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1725_CR19","doi-asserted-by":"publisher","first-page":"35387","DOI":"10.1155\/2007\/35387","volume":"2007","author":"CA Czaja","year":"2007","unstructured":"Czaja CA, Stapleton AE, Yarova-Yarovaya Y, Stamm WE. Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infect Dis Obstet Gynecol. 2007;2007:35387.","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"2","key":"1725_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0928-8244(02)00465-0","volume":"35","author":"G Reid","year":"2003","unstructured":"Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, Bruce AW. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol. 2003;35(2):131\u20134.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"9","key":"1725_CR21","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1001\/archinternmed.2012.777","volume":"172","author":"MA Beerepoot","year":"2012","unstructured":"Beerepoot MA, ter Riet G, Nys S, van der Wal WM, de Borgie CA, de Reijke TM, Prins JM, Koeijers J, Verbon A, Stobberingh E, et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med. 2012;172(9):704\u201312.","journal-title":"Arch Intern Med"},{"issue":"8","key":"1725_CR22","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/0002-9378(83)90972-9","volume":"146","author":"RR Lenke","year":"1983","unstructured":"Lenke RR, VanDorsten JP, Schifrin BS. Pyelonephritis in pregnancy: a prospective randomized trial to prevent recurrent disease evaluating suppressive therapy with nitrofurantoin and close surveillance. Am J Obstet Gynecol. 1983;146(8):953\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1725_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12884-018-1732-2","volume":"18","author":"F Ghouri","year":"2018","unstructured":"Ghouri F, Hollywood A, Ryan K. A systematic review of non-antibiotic measures for the prevention of urinary tract infections in pregnancy. BMC Pregnancy Childbirth. 2018;18(1):99.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1725_CR24","doi-asserted-by":"publisher","first-page":"117037","DOI":"10.1016\/j.bmc.2022.117037","volume":"74","author":"JA Talbert","year":"2022","unstructured":"Talbert JA, Lu J, Spicer SK, Moore RE, Townsend SD, Gaddy JA. Ameliorating adverse perinatal outcomes with Lactoferrin: An intriguing chemotherapeutic intervention. Bioorg Med Chem. 2022;74:117037.","journal-title":"Bioorg Med Chem"},{"key":"1725_CR25","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3389\/fimmu.2020.01221","volume":"11","author":"DB Kell","year":"2020","unstructured":"Kell DB, Heyden EL, Pretorius E. The biology of lactoferrin, an iron-binding protein that can help defend against viruses and bacteria. Front Immunol. 2020;11:1221.","journal-title":"Front Immunol"},{"issue":"9","key":"1725_CR26","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.3390\/ijms18091985","volume":"18","author":"L Rosa","year":"2017","unstructured":"Rosa L, Cutone A, Lepanto MS, Paesano R, Valenti P. Lactoferrin: a natural glycoprotein involved in iron and inflammatory homeostasis. Int J Mol Sci. 2017;18(9):1985.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1725_CR27","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3390\/molecules24071323","volume":"24","author":"MS Lepanto","year":"2019","unstructured":"Lepanto MS, Rosa L, Paesano R, Valenti P, Cutone A. Lactoferrin in aseptic and septic inflammation. Molecules. 2019;24(7):1323.","journal-title":"Molecules"},{"issue":"2","key":"1725_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1055\/s-2007-1016320","volume":"14","author":"DA Grimes","year":"1996","unstructured":"Grimes DA, Schulz KF. Determining sample size and power in clinical trials: the forgotten essential. Semin Reprod Endocrinol. 1996;14(2):125\u201331.","journal-title":"Semin Reprod Endocrinol"},{"issue":"1","key":"1725_CR29","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1186\/s13104-018-3844-1","volume":"11","author":"S Tadesse","year":"2018","unstructured":"Tadesse S, Kahsay T, Adhanom G, Kahsu G, Legese H, Wahid AG, Derbie A. Prevalence, antimicrobial susceptibility profile and predictors of asymptomatic bacteriuria among pregnant women in Adigrat General Hospital, Northern Ethiopia. BMC Res Notes. 2018;11(1):740.","journal-title":"BMC Res Notes."},{"key":"1725_CR30","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13756-017-0289-6","volume":"6","author":"YA Gessese","year":"2017","unstructured":"Gessese YA, Damessa DL, Amare MM, Bahta YH, Shifera AD, Tasew FS, Gebremedhin EZ. Urinary pathogenic bacterial profile, antibiogram of isolates and associated risk factors among pregnant women in Ambo town, Central Ethiopia: a cross-sectional study. Antimicrob Resist Infect Control. 2017;6:132.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1725_CR31","unstructured":"CLSI M100. Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, 35th ed [Available online: http:\/\/www.clsi.org"},{"key":"1725_CR32","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1001\/archinte.1960.00270140016003","volume":"105","author":"EH Kass","year":"1960","unstructured":"Kass EH. Bacteriuria and pyelonephritis of pregnancy. Arch Intern Med. 1960;105:194\u20138.","journal-title":"Arch Intern Med"},{"issue":"Suppl 2","key":"1725_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1365-2362.2008.02009.x","volume":"38","author":"J Schnarr","year":"2008","unstructured":"Schnarr J, Smaill F. Asymptomatic bacteriuria and symptomatic urinary tract infections in pregnancy. Eur J Clin Invest. 2008;38(Suppl 2):50\u20137.","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"1725_CR34","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1086\/427507","volume":"40","author":"LE Nicolle","year":"2005","unstructured":"Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM. Infectious Diseases Society of A, American Society of N, American Geriatric S: Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005;40(5):643\u201354.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1725_CR35","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1128\/JCM.37.3.553-557.1999","volume":"37","author":"S Arao","year":"1999","unstructured":"Arao S, Matsuura S, Nonomura M, Miki K, Kabasawa K, Nakanishi H. Measurement of urinary lactoferrin as a marker of urinary tract infection. J Clin Microbiol. 1999;37(3):553\u20137.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"1725_CR36","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103-120.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1725_CR37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.biochi.2008.05.021","volume":"91","author":"M Tomita","year":"2009","unstructured":"Tomita M, Wakabayashi H, Shin K, Yamauchi K, Yaeshima T, Iwatsuki K. Twenty-five years of research on bovine lactoferrin applications. Biochimie. 2009;91(1):52\u20137.","journal-title":"Biochimie"},{"issue":"3","key":"1725_CR38","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10534-022-00409-1","volume":"36","author":"AL Conte","year":"2023","unstructured":"Conte AL, Longhi C, Conte MP, Costanzo AM, Paesano R, Santangeli S, Venditto F, Tripepi G, Naldi E, Pollio G, et al. Effect of bovine lactoferrin on recurrent urinary tract infections: in vitro and in vivo evidences. Biometals. 2023;36(3):491\u2013507.","journal-title":"Biometals"},{"issue":"5","key":"1725_CR39","doi-asserted-by":"publisher","first-page":"F814","DOI":"10.1152\/ajprenal.00133.2018","volume":"316","author":"KA Bauckman","year":"2019","unstructured":"Bauckman KA, Matsuda R, Higgins CB, DeBosch BJ, Wang C, Mysorekar IU. Dietary restriction of iron availability attenuates UPEC pathogenesis in a mouse model of urinary tract infection. Am J Physiol Renal Physiol. 2019;316(5):F814\u201322.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"1725_CR40","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1039\/C4MT00329B","volume":"7","author":"S Subashchandrabose","year":"2015","unstructured":"Subashchandrabose S, Mobley HL. Back to the metal age: battle for metals at the host-pathogen interface during urinary tract infection. Metallomics. 2015;7(6):935\u201342.","journal-title":"Metallomics"},{"issue":"4","key":"1725_CR41","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1128\/IAI.70.4.1860-1866.2002","volume":"70","author":"E Elass","year":"2002","unstructured":"Elass E, Masson M, Mazurier J, Legrand D. Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycan-binding ability of interleukin-8 in human endothelial cells. Infect Immun. 2002;70(4):1860\u20136.","journal-title":"Infect Immun"},{"issue":"12","key":"1725_CR42","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1002\/cbic.202100016","volume":"22","author":"J Lu","year":"2021","unstructured":"Lu J, Francis JD, Guevara MA, Moore RE, Chambers SA, Doster RS, Eastman AJ, Rogers LM, Noble KN, Manning SD, et al. Antibacterial and Anti-biofilm Activity of the Human Breast Milk Glycoprotein Lactoferrin against Group B Streptococcus. ChemBioChem. 2021;22(12):2124\u201333.","journal-title":"ChemBioChem"},{"issue":"3","key":"1725_CR43","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1139\/o06-053","volume":"84","author":"TJ Ochoa","year":"2006","unstructured":"Ochoa TJ, Brown EL, Guion CE, Chen JZ, McMahon RJ, Cleary TG. Effect of lactoferrin on enteroaggregative E coli (EAEC). Biochem Cell Biol. 2006;84(3):369\u201376.","journal-title":"Biochem Cell Biol"},{"issue":"9","key":"1725_CR44","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.3168\/jds.S0022-0302(93)77594-3","volume":"76","author":"DA Dionysius","year":"1993","unstructured":"Dionysius DA, Grieve PA, Milne JM. Forms of lactoferrin: their antibacterial effect on enterotoxigenic Escherichia coli. J Dairy Sci. 1993;76(9):2597\u2013600.","journal-title":"J Dairy Sci"},{"key":"1725_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.vetmic.2016.05.010","volume":"202","author":"J Rybarczyk","year":"2017","unstructured":"Rybarczyk J, Kieckens E, Vanrompay D, Cox E. In vitro and in vivo studies on the antimicrobial effect of lactoferrin against Escherichia coli O157:H7. Vet Microbiol. 2017;202:23\u20138.","journal-title":"Vet Microbiol"},{"issue":"24","key":"1725_CR46","doi-asserted-by":"publisher","first-page":"e00524","DOI":"10.1128\/AEM.00524-20","volume":"86","author":"M Dierick","year":"2020","unstructured":"Dierick M, Van der Weken H, Rybarczyk J, Vanrompay D, Devriendt B, Cox E. Porcine and bovine forms of lactoferrin inhibit growth of porcine enterotoxigenic escherichia coli and degrade its virulence factors. Appl Environ Microbiol. 2020;86(24):e00524.","journal-title":"Appl Environ Microbiol"},{"issue":"4","key":"1725_CR47","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s10534-011-9423-8","volume":"24","author":"CC Yen","year":"2011","unstructured":"Yen CC, Shen CJ, Hsu WH, Chang YH, Lin HT, Chen HL, Chen CM. Lactoferrin: an iron-binding antimicrobial protein against Escherichia coli infection. Biometals. 2011;24(4):585\u201394.","journal-title":"Biometals"},{"issue":"5","key":"1725_CR48","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269\u201384.","journal-title":"Nat Rev Microbiol"},{"key":"1725_CR49","doi-asserted-by":"publisher","first-page":"562525","DOI":"10.3389\/fcimb.2021.562525","volume":"11","author":"J Josephs-Spaulding","year":"2021","unstructured":"Josephs-Spaulding J, Krogh TJ, Rettig HC, Lyng M, Chkonia M, Waschina S, Graspeuntner S, Rupp J, Moller-Jensen J, Kaleta C. Recurrent urinary tract infections: unraveling the complicated environment of uncomplicated rUTIs. Front Cell Infect Microbiol. 2021;11:562525.","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"1725_CR50","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1159\/000499342","volume":"11","author":"KA Patras","year":"2019","unstructured":"Patras KA, Ha AD, Rooholfada E, Olson J, Ramachandra Rao SP, Lin AE, Nizet V. Augmentation of urinary lactoferrin enhances host innate immune clearance of uropathogenic escherichia coli. J Innate Immun. 2019;11(6):481\u201395.","journal-title":"J Innate Immun"}],"updated-by":[{"DOI":"10.1186\/s12894-025-01929-x","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"record-id":"68816"},{"DOI":"10.1186\/s12894-025-01929-x","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000}}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01725-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-025-01725-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01725-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T13:06:32Z","timestamp":1757941592000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-025-01725-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1725"],"URL":"https:\/\/doi.org\/10.1186\/s12894-025-01725-7","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Editor's Note: Readers are alerted that concerns have been raised regarding the reliability of statistical analysis presented in this article. Further editorial action will be taken if appropriate once the investigation into the concerns is complete and all parties have been given an opportunity to respond in full.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12894-025-01929-x","URL":"https:\/\/doi.org\/10.1186\/s12894-025-01929-x","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was ethically approved from the ethical committee of the Faculty of Medicine, Alexandria University (IRB No: 00012098, Approval No: 0107712, on 14th May 2023). The study was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from each participant before enrolling in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"98"}}